Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy
Nimisha Sulejmani,1 Syed-Mohammed Jafri2 1Department of Pharmacy, Henry Ford Hospital, Detroit, MI, USA; 2Division of Gastroenterology, Henry Ford Hospital, Detroit, MI, USA Abstract: Chronic hepatitis C virus (HCV) infection impacts approximately 71 million people and approximately 400,000 deaths a...
Guardado en:
Autores principales: | Sulejmani N, Jafri SM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b99cf70ffb03438d84369306678c807b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants
por: Li H, et al.
Publicado: (2020) -
First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients
por: Zahra Hasanshahi, et al.
Publicado: (2021) -
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial
por: Zhdanov K, et al.
Publicado: (2020) -
QUANTUM CHEMICAL STUDY OF THE RELATIONSHIPS BETWEEN ELECTRONIC STRUCTURE AND PHARMACOKINETIC PROFILE, INHIBITORY STRENGTH TOWARD HEPATITIS C VIRUS NS5B POLYMERASE AND HCV REPLICONS OF INDOLE-BASED COMPOUNDS
por: DE LA VEGA,AMAYA PAZ, et al.
Publicado: (2013) -
A COMPARISON OF ORAL EVALUATION RATINGS BY NATIVE ENGLISH SPEAKER TEACHERS AND NON-NATIVE ENGLISH SPEAKER TEACHERS
por: Baitman,Brittany, et al.
Publicado: (2013)